Healthcare provider profile · identity verified

Jay Peter Lao, NP

Nurse Practitioner · BRADENTON, FL · NPI 1265920607

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	166
Albuterol Sulfate Hfa	Albuterol Sulfate	332	104
Lisinopril	Lisinopril	274	97
Amlodipine Besylate	Amlodipine Besylate	273	92
Gabapentin	Gabapentin	248	93
Furosemide	Furosemide	236	88
Metformin Hcl	Metformin Hcl	212	72
Levothyroxine Sodium	Levothyroxine Sodium	204	73
Omeprazole	Omeprazole	201	79
Diclofenac Sodium	Diclofenac Sodium	188	103
Rosuvastatin Calcium	Rosuvastatin Calcium	165	62
Trazodone Hcl	Trazodone Hcl	161	51
Pantoprazole Sodium	Pantoprazole Sodium	148	61
Losartan Potassium	Losartan Potassium	139	45
Glipizide	Glipizide	133	45
Metoprolol Tartrate	Metoprolol Tartrate	128	43
Metoprolol Succinate	Metoprolol Succinate	125	46
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	122	95
Fluticasone Propionate	Fluticasone Propionate	113	63
Alendronate Sodium	Alendronate Sodium	112	28
Cephalexin	Cephalexin	107	83
Montelukast Sodium	Montelukast Sodium	100	33
Triamcinolone Acetonide	Triamcinolone Acetonide	95	54
Tizanidine Hcl	Tizanidine Hcl	94	47
Carvedilol	Carvedilol	93	34
Tamsulosin Hcl	Tamsulosin Hcl	93	40
Clopidogrel	Clopidogrel Bisulfate	92	37
Meloxicam	Meloxicam	89	41
Famotidine	Famotidine	81	30
Duloxetine Hcl	Duloxetine Hcl	79	28
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	79	58
Hydrochlorothiazide	Hydrochlorothiazide	77	31
Ibuprofen	Ibuprofen	74	37
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	70	29
Warfarin Sodium	Warfarin Sodium	70	11
Potassium Chloride	Potassium Chloride	69	24
Oxybutynin Chloride Er	Oxybutynin Chloride	63	25
Pioglitazone Hcl	Pioglitazone Hcl	61	24
Hydroxyzine Hcl	Hydroxyzine Hcl	58	28
Simvastatin	Simvastatin	58	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	49
Eliquis	Apixaban	56	21
Azithromycin	Azithromycin	55	41
Ezetimibe	Ezetimibe	54	19
Escitalopram Oxalate	Escitalopram Oxalate	52	15
Fluconazole	Fluconazole	52	15
Prednisone	Prednisone	52	35
Allopurinol	Allopurinol	50	17
Pravastatin Sodium	Pravastatin Sodium	50	14
Citalopram Hbr	Citalopram Hydrobromide	48	17
Januvia	Sitagliptin Phosphate	48	11
Vitamin D2	Ergocalciferol (Vitamin D2)	48	28
Sertraline Hcl	Sertraline Hcl	46	20
Spironolactone	Spironolactone	42	19
Doxycycline Monohydrate	Doxycycline Monohydrate	39	27
Quetiapine Fumarate	Quetiapine Fumarate	38	11
Ozempic	Semaglutide	36	suppressed
Atenolol	Atenolol	34	12
Donepezil Hcl	Donepezil Hcl	34	12
Metformin Hcl Er	Metformin Hcl	34	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Xarelto	Rivaroxaban	31	suppressed
Methylprednisolone	Methylprednisolone	30	19
Naproxen	Naproxen	30	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	28	25
Ondansetron Odt	Ondansetron	28	20
Nifedipine Er	Nifedipine	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Bumetanide	Bumetanide	23	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Finasteride	Finasteride	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Jardiance	Empagliflozin	18	12
Mupirocin	Mupirocin	18	11
Ondansetron Hcl	Ondansetron Hcl	18	12
Benzonatate	Benzonatate	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	15
Baclofen	Baclofen	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Primidone	Primidone	16	suppressed
Estradiol	Estradiol	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Methotrexate	Methotrexate Sodium	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Methimazole	Methimazole	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Temazepam	Temazepam	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Folic Acid	Folic Acid	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lactulose	Lactulose	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Valsartan	Valsartan	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error